Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections.
52W Range
3rdpctl
Volume
0.66×avg
Market Cap
3.47MUSD
P/E Ratio
-0.0TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Moleculin Biotech, Inc.
MBRXNASDAQ Capital Market·USD·Closed
Moleculin Biotech, Inc.
MBRXNASDAQ·USD·Closed
$0.65
−5.63%
$0.65
−$0.04 (5.63%)
52W Range
3rdpctl
Volume
0.66×avg
Mkt Cap
3.47MUSD
P/E
-0.0TTM
Div Yield
–ann
MBRX: Moleculin Biotech, Inc. Stock Analysis | finqOS
